Haider Alleg, Global Head of Digital, FerringNow more than ever, we need to share ideas and collaborate. Reuters Events Pharma's online solution is the answer.
Back for it’s 13th year: Pharma Japan VIRTUAL 2020 is where you will decide your future. The healthcare landscape is evolving and pharma must evolve with it. That’s why we have ensured that our agenda features great insights on how to achieve high effectiveness with limited time and resources. Sometimes this involves digitizing existing processes, sometimes it involves forming new partnerships and sometimes it requires imaginative new business models. We will also provide great case studies from industry leaders and plenty of networking time.
From the Opening Keynote, focusing on future direction of pharma with cutting-edge case studies, to the practical themes covering Digital Clinical Innovation, Commercial Excellence, Medical Affairs & RWE, we will deliver a new direction for your planning.
Be part of the movement to evolve Japan’s pharma industry!
Simone Thomsen President and Representative Director Eli Lilly Japan K. K.
Kensuke Yoshimura, MD. MPH, PhD Specially Appointed Professor and Director Center for Next Generation of Community Health Chiba University Hospital
Taro Goto, M.D., Ph.D. Executive officer, Head of Medical, Japan Bristol-Myers-Squibb KK
Hiroshi Sugii Manager Director/Member of the Board of Directors, Corporate Vice President, CMR Development Division Novo Nordisk Pharma Ltd
Brian Gladsden President, Novartis Oncology Japan Novartis Pharma K.K.
Ajai Sulekh President, Representative Director Biogen Japan Ltd.
Taro Ueno CEO SUSMED Inc.
Stefan Sakurai President / Japan Representative Director LEO Pharma K.K.
Masatsune Okajima President and COO StemRIM
Hiroyuki Yoshihara Representative Director Life Data Initiative, Japan Emeritus Professor Kyoto University and University of Miyazaki, Japan
Eiji Aramaki Associate Professor, PI, Information Science NAIST Graduate School of Science and Technology
Jovelle L. Fernandez Head Japan Medical Office Takeda
Susie Barnes Vice President and Country Medical Director GlaxoSmithKline Japan
Toshinori Kawaguchi Director for Policy Planning, Commerce and Service Industry Policy Group, Healthcare Industries Division Ministry of Economy, Trade and Industry（METI）
David Hernandez Head of Clinical Operations Japan, Global Clinical Operations Merck Biopharma Co., Ltd.
Haider Alleg Global Head of Digital Excellence Ferring Pharmaceuticals
Hiroyuki Taruno Senior director, Medical Affairs Planning Department, Medical Affairs Division Daiichi Sankyo Co., Ltd.
Director, Patient Impact Analysis, Outcome & Evidence,
Corporate affairs, Health & Value Pfizer
Digital transformation: Transform your business model by ensuring you act decisively on customer insights. Recognize the need to digitize. Focus on value with partnerships that deliver holistic patient outcomes.
Evidence-led leadership: Generate great evidence through data. Ensure its communicated well to improve decision-making, portfolio design, patient recruitment and better, medically-driven content.
Deliver patient value to drive commercial & medical excellence: Prove the authenticity of your medicine and care provision with robust data and a great story for HCPs and patient outcomes.
Make Japan a clinical powerhouse: See how data and digital technology can cut costs and time in clinical development. Drive a more patient-centric approach in development to ensure Japan becomes the world's best place to run innovative clinical trials.
Reuters Events Pharma has once again proven why they are the leaders in this space
Wonderful platform. Very valuable.
I couldn’t help but feel that I was witnessing the roots of the future being sown today.
Thank you so much for providing this program virtually… I have learned so much.
An extraordinary, pioneering job!
The Reuters Events Pharma virtual was excellent. The content was relevant, and I enjoyed learning from leaders across Healthcare, Bio Pharma and Technology.
The best Pharma event ever! Speakers with high quality and great background, talking about very updated and helpful contents!
Very informative and educational. Will definitely attend again
Nice quick pivot to virtual space! My first Reuters Events Pharma event... will be checking out more.
Very relevant. Authentic. Pioneering effort.
This is an excellent opportunity to hear from industry leaders as the continue to find innovative ways to optimize healthcare for patients. It’s a tremendous educational resource for all leaders in healthcare.
Excellent facilitation and fascinating discussions
The conference hits on everything I am passionate about.
Craig Lipset, former Head of Innovation at PfizerNow more than ever, society is looking to medicine developers for answers. Quickly moving important gatherings online is vital for innovation continuity and keeping us all making progress for delivering new medicines.
Keynote Get out of your comfort zone and explore the new frontiers of medicine from the ‘digital twin’ to advanced genomics, digital therapeutics, AI and more.
Commercial Excellence A new commercial model is needed to effectively deliver digital transformation. Use technology to provide deeper value to physicians and even patients.
RWE & Medical Make trust your most important principle by communicating in an authentic, scientific way, backed by evidence. Use RWE to speed development, widen access and boost patient outcomes.
Digital Clinical Innovation Cut time and cost through new technology, whilst enabling a more patient-centric approach which boosts recruitment and retention. Recognize that smarter clinical trials could unlock a golden era for pharma.
4 business-critical conference themes
Reuters Events Pharma Japan VIRTUAL 2020 will cover all key topics with four themes: Keynote, Digital Clinical Innovation, RWE & Medical and Commercial Excellence. Which means you’ll gain insights which will help drive your business.
Connect with fellow senior-level attendees in a personalized and user-friendly way. Even you are at your home, we can come together and work towards a better pharma through live Q&A, online networking and workshop sessions.
All stakeholders. All functions. 1 Place.
The most cross-functional pharma event in Japan – decision-makers from marketing, commercial, sales, market access, medical affairs, patient engagement, RWE, digital transformation, IT, clinical and more.
The most senior-level pharma event in Japan
You won’t find a better place to meet your peers since over 80% of the pharma attendees are director-level or above.
Find the solution
Sometimes, the best ideas don’t come from the stage. They come from those chance happenings when you join a workshop or attend an interactive session. Reuters Events Pharma Japan VIRTUAL 2020 is packed with opportunities for you to connect with prospective collaborators and idea generators.
Drive the future
Experts and thought leaders will share cutting edged case studies. Re-position your strategy and teams aligned to the industry’s next movement.
Jovelle L. Fernandez, MD, PhD, FPOGS, Head, Japan Medical Office, Takeda Pharmaceutical CompanyReuters Events Pharma Japan Conference is a useful platform to be informed about recent trends in pharma industry.
Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it.
77% of attendees are director-level and above
Reuters Events Pharma Japan attracts a variety of job titles, geographies, cultures and opinions create a rich tapestry.
Satoru Noguchi, Ex-executive Pharma and Principal, GlobalMindsetAs times change, Reuters Events Pharma Japan always captures the current and future trends to help us grow our business.
Haider Alleg, Global Head of Digital Excellence / GMO, Ferring International CenterReuters Events Pharma Japan is a thriving community of experts exchanging opinions and finding answers. You will meet peers who understand and will help to propel your ideas forward.
Yasuyuki Katayama, Corporate Officer, Country Medical Director and Head of Medical Japan, Pfizer Japan Inc.Reuters Events Pharma Japan is where leaders gather and find direction, opportunities and partnerships.
Katsunori Ohyama, Director, Severe asthma dedicated sales force, GlaxoSmithKline K.K.Reuters Events Pharma Japan is always at the forefront of the pharma industry’s next movement.
Get in touch with the Pharma Japan team
Blair Gottscho VP Operations
Hiromasa Araki Business Development Executive, Japan
Itsumi Nishikawa Project Director
Akari Ueda Project Director, Japan
Ross McMullan Business Development Director